EUVIMEDEUVIMED entdecken
Crossref

NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis

Claire Delehouzé, Stéphane Bach

Ferroptosis and Oxidative Stress · 2026

DOI: 10.70401/fos.2026.0041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2026. Verfasst von Claire Delehouzé und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past two decades, increasing attention has been devoted to regulated forms of cell death that occur independently of apoptosis. Among these, necroptosis and ferroptosis exhibit a necrotic-like morphology, yet are defined by distinct molecular and biochemical signatures. Both pathways have attracted considerable interest due to growing evidence implicating them in the pathogenesis of a wide range of acute and chronic disorders. Notably, the simultaneous engagement of multiple regulated necrosis pathways has been reported in many disease contexts, highlighting the limitations of single-target therapeutic approaches. In this light, the design of multi-target-directed ligands, that is, embracing a polypharmacological strategy, has emerged as a promising direction for the development of future therapies. In this review, we propose the concept of NecroFerrins, a class of small molecules that simultaneously inhibit necroptosis and ferroptosis. Within this class, we identify RIPROStatins as a distinct subclass of RIPK1 inhibitors that additionally possess radical-trapping antioxidant activity. The objective of this review is also to stimulate translational research on complex diseases using polypharmacological drugs acting as necrosis inhibitors.

Zitieren

APA

Delehouzé, C., & Bach, S. (2026). NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0041

Vancouver

Delehouzé C, Bach S. NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis. Ferroptosis and Oxidative Stress. 2026. doi:10.70401/fos.2026.0041

BibTeX
@article{Delehouz2026,
  author = {Delehouzé, Claire and Bach, Stéphane},
  title = {NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis},
  journal = {Ferroptosis and Oxidative Stress},
  year = {2026},
  doi = {10.70401/fos.2026.0041}
}
Kostenlos starten →